Elinor Cohen - RxE2 | Pharmacists Unbound

RxE2 Revolutionizes Clinical Trials with Groundbreaking AI-led Technology Platform and Marketplace

Press ReleasesBy Elinor Cohen December 4, 2023

FARGO, N.D., Dec. 4, 2023 /PRNewswire/ — RxE2, the pioneer in pharmacy-led medical innovation, announces the launch of a groundbreaking technology platform that redefines the clinical trial landscape. RxE2 is the first technology company to seamlessly connect independent community pharmacies with the forefront of healthcare innovation, ushering in a new era of patient-centric and cost-effective clinical research. At the…

The Vital Difference: Independent Community Pharmacies vs. Chain Pharmacies

Blog, Clinical TrialsBy Elinor Cohen November 3, 2023

Introduction In today’s fast-paced world, pharmacies play a vital role in granting people access to fundamental medicines and health services. There are two primary categories of pharmacies: independent community pharmacies and chain pharmacies. Despite serving as crucial healthcare facilities, they differ greatly in treating patients, offering customized services, and incorporating with the community. In this…

Meet our CEO at PharmSci360 in Florida!

NewsBy Elinor Cohen October 8, 2023

Join our session RxE2 CEO, Gerald Finken, will be taking part in a panel titled: “The Integration of Clinical Trials and Clinical Care: A Revolution in the Participant and Sponsor Experience or an Implementation Nightmare? Or Both?” When & Where Monday, October 23, 2023 | 7:00 AM – 9:00 AM ET | Location:308 AB West Meet…

RxE2 Once again named one of the best Tech Startups in North Dakota!

NewsBy Elinor Cohen September 22, 2023

For the second consecutive year we’ve made the list of best tech startups! The Tech Tribune staff has compiled a list of the best tech startups in North Dakota. Several factors were considered in their research, including but not limited to: Revenue potential Leadership team Brand/product traction Competitive landscape RxE2 is honored to have been…

RxE2 welcomes Doug Liberi as Vice President of Business Development & Sales

News, Press ReleasesBy Elinor Cohen August 23, 2023

Fargo, ND August 17 2023 – RxE2 announces the appointment of Doug Liberi as VP of Business Development and Sales. In his role as VP of business development, Mr. Liberi will be in charge of category creation and market expansion for RxE2, leading the company’s sales team strategically. “I am happy Doug has agreed to…

Imagine where your Clinical Trials can go…

BlogBy Elinor Cohen July 27, 2023

While RxE2 continues promoting the practice of pharmacy and community-based pharmacists in clinical trials in the United States, the European Association of Hospital Pharmacies (EAHP) is encouraging the involvement of hospital pharmacists in European clinical trials. RxE2 applauds the EAHP for taking a position on clinical trials and their recognition of the valuable contributions pharmacists…

RxE2 is proud to, once again, pledge $27,500 to NorthStar Development Cycling Club

News, Press ReleasesBy Elinor Cohen June 15, 2023

Fargo, ND, June 15, 2023 – This is the third year in which RxE2, led by CEO and two-time USA Cycling Masters National Cycling Champion, Gerald Finken, pledges $27,500 the NorthStar Cycling Club. “For over ten years NorthStar Development Cycling has shared the thrill of competitive cycling with scores of school-aged kids. Gerald Finken has…

Meet us at GCSG 2023!

NewsBy Elinor Cohen April 19, 2023

RxE2 is disrupting the clinical supply chain to improve quality and eliminate waste – Meet us at #GCSG2023! Current supply chain logistics provide ample opportunity for risk and waste. What if we eliminate that? Led by Gerald E. Finken, the inventor of On-Demand Packaging & Labeling, RxE2 is de-risking the process by eliminating unnecessary steps for truly patient centric…

“Diversity Now” Protocol – Powered by RxE2

Clinical Trials, White PapersBy Elinor Cohen February 17, 2023

Diversity Now, the first protocol to achieve diversity in clinical trials according to the FDA guidelines for Race and Ethnicity Diversity Plans This plan provides a pharmacist-centered approach for compliance with Section V Categories 4 and 5 of the US Food and Drug Administration’s industry guidance (hereinafter “FDA Guidance”) for developing the required Race and…

Diversity in Clinical Trials – How to stop talking about it and actually do it

Blog, Clinical TrialsBy Elinor Cohen January 8, 2023

Diversity in Clinical Trials – Background The Federal Drug Administration (FDA) issued non-compulsory guidance on clinical trial diversity to encourage diverse populations in clinical trials and improve the applicability of clinical trial results. The guidance recommends diverse clinical trial populations to better understand the safety and effectiveness of medical products across race, ethnicity, and gender.…

Author Archives: Elinor Cohen